共 50 条
- [1] A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancerCancer Chemotherapy and Pharmacology, 2010, 66 : 287 - 294Steven J. CohenMark M. ZalupskiManuel R. ModianoPaul ConklingYehuda Z. PattPeg DavisRobert T. DorrMichelle L. BoytimEvan M. Hersh
- [2] A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 287 - 294Cohen, Steven J.Zalupski, Mark M.Modiano, Manuel R.Conkling, PaulPatt, Yehuda Z.Davis, PegDorr, Robert T.Boytim, Michelle L.Hersh, Evan M.
- [3] Phase I trial of imexon, Inj. plus gemcitabine in patients with advanced previously untreated pancreatic adenocarcinomaJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Cohen, S. J.Zalupski, M.Modiano, M.Conkling, P.Mahadevan, D.Wong, L.Smith, D.Dorr, R. T.Boytim, M.Hersh, E. M.
- [4] A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerMEDICINE, 2021, 100 (20) : E26052Fukahori, MasaruMiwa, KeisukeMurotani, KentaNaito, YoshikiUshijima, TomoyukiSakaue, TakahikoTanaka, ToshimitsuNagasu, SachikoSuga, HideyaKakuma, TatsuyukiOkabe, YoshinobuTorimura, Takuji
- [5] Gemcitabine Plus Irinotecan as First-Line Weekly Therapy in Locally Advanced and/or Metastatic Pancreatic CancerONCOLOGY RESEARCH, 2009, 17 (11-12) : 559 - 564Neri, B.Cipriani, G.Grifoni, R.Molinara, E.Pantaleo, P.Rangan, S.Vannini, A.Tonelli, P.Valeri, A.Pantalone, D.Taddei, A.Bechi, P.
- [6] Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trialCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1431 - 1438Fogelman, DavidJafari, MehrdadVaradhachary, Gauri R.Xiong, HenryBullock, SusieOzer, HaroldLin, E.Morris, JeffreyCunningham, PattiBennett, BronwynAbbruzzese, James L.Wolff, Robert A.
- [7] Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II studyCancer Chemotherapy and Pharmacology, 2009, 64 : 317 - 325Kyung Hee LeeMin Kyoung KimYeol Hong KimBaek Yeol RyooHo Yeong LimHong Suk SongHoon Kyo KimMyung Ah LeeSeock Ah ImHeung Moon ChangJae Yong ChoDae Young ZangBong Seog KimJun Suk Kim
- [8] Gemcitabine and oxaliplatin combination as the first-line treatment in advanced pancreatic cancer: A multicenter phase II studyJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Lee, K.Kim, M.Kim, Y.Ryoo, B.Lim, H.Song, H.Kim, H.Lee, M.Im, S.Chang, H.Cho, J.
- [9] Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II studyCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 317 - 325Lee, Kyung HeeKim, Min KyoungKim, Yeol HongRyoo, Baek YeolLim, Ho YeongSong, Hong SukKim, Hoon KyoLee, Myung AhIm, Seock AhChang, Heung MoonCho, Jae YongZang, Dae YoungKim, Bong SeogKim, Jun Suk
- [10] Phase II study of sorafenib with gemcitabine and erlotinib (GES) in first-line advanced pancreatic cancer.JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)Cohen, D. J.Leichman, L. P.Love, E.Ryan, T.Leichman, C. G.Newman, E.Levinson, B.Hochster, H. S.